A federal judge in Washington ordered CVS Health Corp. to comply with a document request from the US Federal Trade Commission, a win for the antitrust and consumer protection agency in its long-running conflict with drug benefits middlemen.

FTC court order requires CVS Health to share more documents about Caremark Rx PBM practices as part of ongoing investigation into anticompetitive behavior in pharmacy benefits market.

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and with unparalleled accuracy. Back To Top

With over 105 million caregivers in the U.S., CVS Health provides essential support and resources to help those caring for loved ones. #PaidForContent

After underperforming throughout 2024, shares of CVS Health (NYSE: CVS) are surging. From the end of 2024 through Feb. 14, the stock climbed 46.7% higher. Shares of the healthcare conglomerate stock notched significant gains after management presented an encouraging fourth-quarter earnings report on Wednesday,

CVS Health (NYSE: CVS) announced Friday that it has reduced employee bonuses due to lower-than-expected profits in 2024. The healthcare giant faced mounting costs, particularly from its Medicare plans,

CVS Health topped fourth-quarter earnings estimates, but still saw profit slide 38% from a year ago. "We have continued to see growth in key areas of our business, including the Pharmacy and Consumer Wellness segment,

CVS Health Corp (NYSE:CVS) reported fourth-quarter sales of $97.71 billion, beating the consensus of $97.19 billion. Total revenues increased 4.2%, driven by growth in the Health Care Benefits and Pharmacy & Consumer Wellness segments,

CVS Health (CVS) stock soared about 15% yesterday after posting upbeat fourth-quarter results, with revenues and earnings surpassing analysts’

Ed DeVaney’s promotion is the latest leadership shakeup at CVS Health as the company works on a multi-year turnaround plan.

Our drive to greater drug pricing transparency through innovation has never been more needed,” Ed DeVaney says.

Today, CVS Health® (NYSE: CVS) named Ed DeVaney president of the company's CVS Caremark pharmacy benefit management business. He was named interim president in December 2024. DeVaney will report ...